68 and FX2149 attenuate mutant LRRK2-R1441C-induced neural transport impairment

Joseph M. Thomas, Tianxia Li, Wei Yang, Fengtian Xue, Paul S. Fishman, Wanli Smith

Research output: Contribution to journalArticle

Abstract

Leucine-rich repeat kinase 2 is a large protein with implications in genetic and sporadic causes of Parkinson's disease. The physiological functions of LRRK2 are largely unknown. In this report, we investigated whether LRRK2 alters neural transport using live-cell imaging techniques and human neuroblastoma SH-SY5Y cells. Our results demonstrated that expression of the PD-linked mutant, LRRK2-R1441C, induced mitochondrial, and lysosomal transport defects in neurites of SH-SY5Y cells. Most importantly, recently identified GTP-binding inhibitors, 68 and FX2149, can reduce LRRK2 GTP-binding activity and attenuates R1441C-induced mitochondrial and lysosomal transport impairments. These results provide direct evidence and an early mechanism for neurite injury underlying LRRK2-induced neurodegeneration. This is the first report to show that LRRK2 GTP-binding activity plays a critical role during neurite transport, suggesting inhibition of LRRK2 GTP-binding could be a potential novel strategy for PD intervention.

Original languageEnglish (US)
Article number337
JournalFrontiers in Aging Neuroscience
Volume8
Issue numberJAN
DOIs
StatePublished - Jan 10 2017

Fingerprint

Guanosine Triphosphate
Neurites
Neuroblastoma
Leucine
Parkinson Disease
Phosphotransferases
Wounds and Injuries
Proteins

Keywords

  • GTP binding inhibitor
  • LRRK2
  • Lysosomes
  • Mitochondria
  • Neural transport
  • Parkinson's disease

ASJC Scopus subject areas

  • Aging
  • Cognitive Neuroscience

Cite this

68 and FX2149 attenuate mutant LRRK2-R1441C-induced neural transport impairment. / Thomas, Joseph M.; Li, Tianxia; Yang, Wei; Xue, Fengtian; Fishman, Paul S.; Smith, Wanli.

In: Frontiers in Aging Neuroscience, Vol. 8, No. JAN, 337, 10.01.2017.

Research output: Contribution to journalArticle

Thomas, Joseph M. ; Li, Tianxia ; Yang, Wei ; Xue, Fengtian ; Fishman, Paul S. ; Smith, Wanli. / 68 and FX2149 attenuate mutant LRRK2-R1441C-induced neural transport impairment. In: Frontiers in Aging Neuroscience. 2017 ; Vol. 8, No. JAN.
@article{cdd80fe8dc7e4e64b00b16c66686426b,
title = "68 and FX2149 attenuate mutant LRRK2-R1441C-induced neural transport impairment",
abstract = "Leucine-rich repeat kinase 2 is a large protein with implications in genetic and sporadic causes of Parkinson's disease. The physiological functions of LRRK2 are largely unknown. In this report, we investigated whether LRRK2 alters neural transport using live-cell imaging techniques and human neuroblastoma SH-SY5Y cells. Our results demonstrated that expression of the PD-linked mutant, LRRK2-R1441C, induced mitochondrial, and lysosomal transport defects in neurites of SH-SY5Y cells. Most importantly, recently identified GTP-binding inhibitors, 68 and FX2149, can reduce LRRK2 GTP-binding activity and attenuates R1441C-induced mitochondrial and lysosomal transport impairments. These results provide direct evidence and an early mechanism for neurite injury underlying LRRK2-induced neurodegeneration. This is the first report to show that LRRK2 GTP-binding activity plays a critical role during neurite transport, suggesting inhibition of LRRK2 GTP-binding could be a potential novel strategy for PD intervention.",
keywords = "GTP binding inhibitor, LRRK2, Lysosomes, Mitochondria, Neural transport, Parkinson's disease",
author = "Thomas, {Joseph M.} and Tianxia Li and Wei Yang and Fengtian Xue and Fishman, {Paul S.} and Wanli Smith",
year = "2017",
month = "1",
day = "10",
doi = "10.3389/fnagi.2016.00337",
language = "English (US)",
volume = "8",
journal = "Frontiers in Aging Neuroscience",
issn = "1663-4365",
publisher = "Frontiers Research Foundation",
number = "JAN",

}

TY - JOUR

T1 - 68 and FX2149 attenuate mutant LRRK2-R1441C-induced neural transport impairment

AU - Thomas, Joseph M.

AU - Li, Tianxia

AU - Yang, Wei

AU - Xue, Fengtian

AU - Fishman, Paul S.

AU - Smith, Wanli

PY - 2017/1/10

Y1 - 2017/1/10

N2 - Leucine-rich repeat kinase 2 is a large protein with implications in genetic and sporadic causes of Parkinson's disease. The physiological functions of LRRK2 are largely unknown. In this report, we investigated whether LRRK2 alters neural transport using live-cell imaging techniques and human neuroblastoma SH-SY5Y cells. Our results demonstrated that expression of the PD-linked mutant, LRRK2-R1441C, induced mitochondrial, and lysosomal transport defects in neurites of SH-SY5Y cells. Most importantly, recently identified GTP-binding inhibitors, 68 and FX2149, can reduce LRRK2 GTP-binding activity and attenuates R1441C-induced mitochondrial and lysosomal transport impairments. These results provide direct evidence and an early mechanism for neurite injury underlying LRRK2-induced neurodegeneration. This is the first report to show that LRRK2 GTP-binding activity plays a critical role during neurite transport, suggesting inhibition of LRRK2 GTP-binding could be a potential novel strategy for PD intervention.

AB - Leucine-rich repeat kinase 2 is a large protein with implications in genetic and sporadic causes of Parkinson's disease. The physiological functions of LRRK2 are largely unknown. In this report, we investigated whether LRRK2 alters neural transport using live-cell imaging techniques and human neuroblastoma SH-SY5Y cells. Our results demonstrated that expression of the PD-linked mutant, LRRK2-R1441C, induced mitochondrial, and lysosomal transport defects in neurites of SH-SY5Y cells. Most importantly, recently identified GTP-binding inhibitors, 68 and FX2149, can reduce LRRK2 GTP-binding activity and attenuates R1441C-induced mitochondrial and lysosomal transport impairments. These results provide direct evidence and an early mechanism for neurite injury underlying LRRK2-induced neurodegeneration. This is the first report to show that LRRK2 GTP-binding activity plays a critical role during neurite transport, suggesting inhibition of LRRK2 GTP-binding could be a potential novel strategy for PD intervention.

KW - GTP binding inhibitor

KW - LRRK2

KW - Lysosomes

KW - Mitochondria

KW - Neural transport

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=85012198790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012198790&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2016.00337

DO - 10.3389/fnagi.2016.00337

M3 - Article

C2 - 28119604

AN - SCOPUS:85012198790

VL - 8

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

SN - 1663-4365

IS - JAN

M1 - 337

ER -